Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,28118,300 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY / ABSTRACT: Nanoparticles (NPs) hold great promise for delivering more effective and safer cancer treatment than the small molecule drugs that are commonly used. Th...

$5.7M
USD
Completed TRAINING, INSTITUTIONAL
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions
NATIONAL CANCER INSTITUTE Rbhs -Cancer Institute of New Jersey United States 2021 – 2026

Rutgers Cancer Institute of New Jersey (RCINJ) provides an outstanding environment for training in basic, clinical, behavioral or population-based cancer research and brings togeth...

$1.47M
USD
Completed NON-SBIR/STTR RPGS
Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

PROJECT SUMMARY Chemotherapy-induced Peripheral Neuropathy (CIPN) is one of the most harmful, common, painful, and disabling side effects of many chemotherapy agents and there is n...

$7.3M
USD
Completed NON-SBIR/STTR RPGS
Identification of TR4 Modulators for Treatment of Cushing Disease.
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2021 – 2023

ABSTRACT Cushing Disease (CD) is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor that causes excess adrenal-derived cortisol.It is a life-threatening ?orp...

$4.01M
USD
Completed NON-SBIR/STTR RPGS
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2021 – 2026

PROJECT SUMMARY Ovarian cancer is a silent killer that strikes with few, if any, symptoms. By the time a woman knows she has it, the cancer is often advanced and the outlook grim....

$6.55M
USD
Completed NON-SBIR/STTR RPGS
Lung Resident Mesenchymal Cells in the Pre-Metastatic Niche Formation
NATIONAL CANCER INSTITUTE Jackson Laboratory United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Metastatic disease remains the major cause of cancer-related death. Among the vital organs to which solid tumors metastasize, the lung is one of the most c...

$4.84M
USD
Completed NON-SBIR/STTR RPGS
Role of Transcription Factor ADP-ribosylation in Breast Cancer Biology
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Project Summary/Abstract The molecular heterogeneity of cancers poses a major hurdle for treatment and drug discovery efforts.Previous studies have addressed this challenge by char...

$4.11M
USD
Completed NON-SBIR/STTR RPGS
Targeting allosteric scaffolding functions of Aurora kinase A in cancer
NATIONAL CANCER INSTITUTE University of Minnesota United States 2021 – 2026

ABSTRACT Neuroblastoma is the most common solid tumor in infants.About 25% of patients have high-risk neuroblastoma, a devastating disease with poor prognosis and few treatment opt...

$3.54M
USD
Completed NON-SBIR/STTR RPGS
Targeting Lymph Node Dependent Immune Tolerance in Cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

Project Summary Background: Malignant melanoma and pancreatic ductal adenocarcinoma (PDAC) typically spread to lymph nodes (LNs) prior to outgrowth in distant tissues.While metasta...

$5.32M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2021 – 2021

ABSTRACT E2f (E2f1-8) transcription factors are critical regulators of cell cycle and their activity is physically regulated by Rb family proteins (Rb, p107 and p130). Disruption o...

$1.06M
USD
Completed NON-SBIR/STTR RPGS
Predicting Relapse at the Time of Diagnosis in Acute Lymphoblastic Leukemia
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY Relapse is the major cause of cancer related mortality in children with leukemia.Despite improvements in overall survival for children with B-cell progenitor acute...

$6.16M
USD
Completed NON-SBIR/STTR RPGS
Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

ABSTRACT Recent advances in chromatin conformation capture techniques have revolutionized our understanding of chro- matin organization and have provided novel insights at an unpre...

$6.13M
USD
Completed NON-SBIR/STTR RPGS
Predicting sensitivity and resistance in RET-driven cancers
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Selpercatinib (LOXO-292) is a highly active selective RET inhibitor explored on an ongoing registrational program (LIBRETTO-001 phase 1/2 trial) in RET-dependent cancers (US FDA ap...

$4.05M
USD
Completed NON-SBIR/STTR RPGS
Regulation of DGAT - dependent lipogenesis in colonic epithelial growth
NATIONAL CANCER INSTITUTE Tulane University of Louisiana United States 2021 – 2026

Abstract Obesity is characterized by systemic lipid accumulation, inflammation, and enhanced tumorigenesis in different tissues, including colon. With obesity, intracellular lipid...

$3.29M
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of Epigenetic Plasticity in PDAC
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDAC) is one of the most deadly human cancers and in ~95% of cases driven by oncogenic mutations of Kras.Unfortunately, attempts to directly inhib...

$5.07M
USD
Completed NON-SBIR/STTR RPGS
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Research Center United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT Recent advances in targeted therapies have revolutionized lung cancer clinical practice.Lung adenocarcinomas harbor frequent mutations/amplifications/fusio...

$4.67M
USD
Completed NON-SBIR/STTR RPGS
Improving efficacy of radioiodine treatment of thyroid cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

Patients with advanced thyroid cancer are frequently refractory to radioiodine (RAI) therapy.Oncoproteins that constitutively activate MAPK signaling suppress expression of genes t...

$4.71M
USD
Completed NON-SBIR/STTR RPGS
Deconstructing and targeting aneuploidy in human cancer - Resubmission - 1
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

Summary Aneuploidy?the presence of chromosome gains and losses?is very rare in normal tissues but occurs in more than 80% of human tumors, especially in solid tumors.A high level o...

$4.46M
USD
Completed NON-SBIR/STTR RPGS
Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is a leading cause of cancer death in the United States. National guidelines recommend that average risk people receive regular CRC...

$6.93M
USD
Completed NON-SBIR/STTR RPGS
Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

Breast mammography is one of the most successful cancer screening tools in the cancer prevention arsenal. 37 million women in the US will receive a mammogram this year, and followi...

$7.03M
USD